首页 > 市场调查报告书 > 医疗设备

透析机设备

市场调查报告书

商品编码

1471955

连续性肾臟替代疗法市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、方式和最终用户

Continuous Renal Replacement Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Modality, and End User

出版日期: 2024年03月18日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

根据我们最新的《2030 年连续性肾臟替代疗法市场预测 - 全球分析 - 产品、方式、最终用户和地理》研究显示，2022 年市场估值为 14.2 亿美元，预计将达到 27.5 亿美元到 2030 年；预计2022年至2030年复合年增长率为8.7%。

连续性肾臟替代治疗 (CRRT) 已成为入住 ICU 接受 AKI 治疗的儿童的建议透析选择。由于多种儿科疾病的存在，儿科人群中肾臟替代的适应症发生了变化。 CRRT 的应用范围已扩大，其在治疗非肾臟适应症（主要是危重新生儿）的有效性已得到证实。例如，Medtronic 的 Carpediem 系统为低体重患者提供专用的体外 CRRT；根据该公司的说法，该设备可以有效地满足最脆弱患者的需求。此外，百特的 PRISMASOL 和 PHOXILLUM 解决方案被指定为 CRRT 中的替代解决方案，以取代超滤去除的血浆量，并纠正儿科和成人患者的电解质和酸碱失衡。因此，对儿科 CRRT 设备的需求增加有利于肾臟替代治疗市场的持续成长。

按产品划分，持续肾臟替代疗法市场洞察

根据产品，连续性肾臟替代疗法市场分为透析液和替代液、一次性用品、血管套件和管道、CRRT 系统和血液过滤器。 CRRT 系统细分市场在 2022 年占据最大市场份额。血滤器由中空纤维膜组成，可控制排出的液体和溶质的体积。透过消除溶质（废物、电解质和其他分子），CRRT 滤血器膜模仿肾臟的一些活动。此外，它们还可以透过其功能来帮助恢復体液状态和酸碱平衡。

按最终用户，持续肾臟替代治疗市场洞察

依最终用户划分，连续肾臟替代治疗市场分为医院、门诊护理中心、家庭护理等。 2022年，医院细分市场将主导持续性肾臟替代治疗市场。家庭监控领域预计在 2022 年至 2030 年期间复合年增长率最高。根据美国医院协会的数据，到 2023 年，美国有 5,157 家社区医院、206 家联邦政府医院和 107 家其他医院。此外，老年人口的不断增长和 AKI 住院人数的显着增加是推动医院 CRRT 系统需求的关键因素。

美国国立卫生研究院、公司的投资者报告和世界卫生组织是在准备连续性肾臟替代疗法市场报告时提到的一些主要二手来源。

According to our latest study on " Continuous Renal Replacement Therapy Market Forecast to 2030 - Global Analysis -Product, Modality, End User, and Geography," the market was valued at US$ 1.42 billion in 2022 and is expected to reach US$ 2.75 billion by 2030; it is estimated to register a CAGR of 8.7% from 2022 to 2030.

Continuous renal replacement therapy (CRRT) has become the recommended dialysis option for children admitted to ICUs for AKI treatments. The indications for renal replacement in the pediatric population have changed due to a wide range of pediatric diseases. The range of CRRT applications has expanded with its proven effectiveness in treating nonrenal indications, primarily, in critically ill newborns. For instance, the Carpediem system by Medtronic offers a dedicated extracorporeal CRRT for low-weight patients; as per the company's claims, the device responds effectively to the needs of the most fragile patients. Moreover, PRISMASOL and PHOXILLUM solutions by Baxter are indicated as a replacement solution in CRRT to replace plasma volume removed by ultrafiltration as well as to correct electrolyte and acid-base imbalances in pediatric and adult patients. Thus, the increased demand for pediatric CRRT devices benefits the continuous renal replacement therapy market growth.

By Product, Continuous Renal Replacement Therapy Market-Based Insights

Based on product, the continuous renal replacement therapy market is segmented into dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. The CRRT systems segment held the largest share of the market in 2022. The hemofilters segment is likely to register the highest CAGR in the market during 2022-2030. The hemofilters are composed of a hollow-fiber membrane that controls the volume of fluids and solutes evacuated. By eliminating solutes (waste products, electrolytes, and other molecules), CRRT hemofilter membranes imitate some of the activities of the kidney. Moreover, they may help restore fluid status and acid-base balance through their function.

By End User, Continuous Renal Replacement Therapy Market-Based Insights

The continuous renal replacement therapy market, by end-user, is segmented into hospitals, ambulatory care centers, home care, and others. In 2022, the hospital segment dominated the continuous renal replacement therapy market share. The home monitoring segment is expected to register the highest CAGR during 2022-2030. In 2023, the US had 5,157 community hospitals, 206 federal government hospitals, and 107 other hospitals, according to the American Hospital Association. Further, the growing elderly population and the notable rise in hospital admissions for AKI are the key factors that propel the demand for CRRT systems in hospitals.

National Institutes of Health, company's investor reports, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the continuous renal replacement therapy market.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Continuous Renal Replacement Therapy Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Continuous Renal Replacement Therapy Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Continuous Renal Replacement Therapy Market - Global Market Analysis

6.1 Continuous Renal Replacement Therapy - Global Market Overview
6.2 Continuous Renal Replacement Therapy - Global Market and Forecast to 2030

7. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By Product, 2020-2030

7.1 Overview
7.2 Dialysates and Replacement Fluids
7.3 Disposables
7.4 Bloodline Sets and Tubes
7.5 Hemofilters
7.6 CRRT Systems

8. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By Modality, 2020-2030

8.1 Overview
8.2 Continuous venovenous hemofiltration (CVVH)
8.3 Continuous venovenous hemodiafiltration (CVVHDF)
8.4 Continuous venovenous hemodialysis (CVVHD)
8.5 Slow continuous ultrafiltration (SCUF)

9. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospital
9.3 Ambulatory care
9.4 Homecare
9.5 Others

10. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Continuous Renal Replacement Therapy Market Overview
- 10.1.2 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts to 2030
- 10.1.3 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Product
- 10.1.4 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Modality
- 10.1.5 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Continuous Renal Replacement Therapy Market
    - 10.1.6.1.1 United States Continuous Renal Replacement Therapy Market, by Product
    - 10.1.6.1.2 United States Continuous Renal Replacement Therapy Market, by Modality
    - 10.1.6.1.3 United States Continuous Renal Replacement Therapy Market, by End User
  - 10.1.6.2 Canada Continuous Renal Replacement Therapy Market
    - 10.1.6.2.1 Canada Continuous Renal Replacement Therapy Market, by Product
    - 10.1.6.2.2 Canada Continuous Renal Replacement Therapy Market, by Modality
    - 10.1.6.2.3 Canada Continuous Renal Replacement Therapy Market, by End User
  - 10.1.6.3 Mexico Continuous Renal Replacement Therapy Market
    - 10.1.6.3.1 Mexico Continuous Renal Replacement Therapy Market, by Product
    - 10.1.6.3.2 Mexico Continuous Renal Replacement Therapy Market, by Modality
    - 10.1.6.3.3 Mexico Continuous Renal Replacement Therapy Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of SouthEast Asia
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 U.A.E
- 10.4.3 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Continuous Renal Replacement Therapy Market - Key Company Profiles

13.1 Baxter International Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies